Skip to main content
. 2013 Feb 4;81(2):423–436. doi: 10.3797/scipharm.1301-13

Tab. 1.

Anticancer screening at a single concentration of 10−5 M against 60 cancer cell lines

Cpd. Mean growth % Interval of growth % The most sensitive cell lines Growth % of the most sensitive cell line Active (selected for 5-dose 60 cell lines assay)
4f 1.77 −96.40 to 85.42 SK-MEL-5 (melanoma) −96.40 Y
M14 (melanoma) −80.36
MALME-3M (melanoma) −66.70
4i 17.75 −74.12 to 77.31 SK-MEL-25 (melanoma) −74.12 Y
SF-295 (CNS cancer) −50.25
MDA-MB-435 (breast cancer) −48.22